New research suggests that patients who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who stop traditional lifestyle regimens.
Research printed in a leading health publication points out that while obese people frequently drop a large proportion of their total mass while on the medication, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals buying such medications need to be aware of the danger of quick weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery suggests a return to starting weight within about one and a half years.
Comparing Therapies
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
Scientists emphasize that people who lose weight through lifestyle changes alone usually have a less rapid weight regain—around 100 grams monthly—once they finish.
Explaining the Quick Regain
Experts suggest the mode of action of the injections explains the accelerated rebound.
The injections mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone levels far above than normal could lead to the body to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in appetite is unsuppressed, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, due to the significant potential of weight regain, the treatment is often long-term.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the long-term nature of obesity," akin to managing diseases like high blood pressure.
User Testimonies
Users who have discontinued the jabs describe a intense resurgence of appetite.
"I experienced something that goes on and you're instantly ravenous," recalled an individual.
The struggle is exacerbated if users have not adopted permanent lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Use is more common among females than males.
- The middle-aged age group shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians stress that while these medications are powerful agents for shedding pounds, they are not a magic fix and lasting health benefits likely depends on integrated behavioural management.
